Title |
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR
|
---|---|
Published in |
Trials, July 2020
|
DOI | 10.1186/s13063-020-04595-6 |
Pubmed ID | |
Authors |
Jan H. Terheyden, Frank G. Holz, Steffen Schmitz-Valckenberg, Anna Lüning, Matthias Schmid, Gary S. Rubin, Hannah Dunbar, Adnan Tufail, David P. Crabb, Alison Binns, Clara I. Sánchez, Carel Hoyng, Philippe Margaron, Nadia Zakaria, Mary Durbin, Ulrich Luhmann, Parisa Zamiri, José Cunha-Vaz, Cecília Martinho, Sergio Leal, Robert P. Finger, P. Basile, C. Behning, M. Berger, A. Binns, M. Böttger, C. Bouchet, J. E. Brazier, T. Butt, C. Carapezzi, J. Carlton, A. Charil, R. Coimbra, S. Nunes, D. Crabb, J. Cunha-Vaz, H. Dunbar, M. Durbin, R. Finger, F. Holz, C. Hoyng, J. Krätzschmar, S. Leal, U. Luhmann, A. Lüning, Ph. Margaron, C. Martinho, B. Melício, S. Mohand-Saïd, D. Rowen, G. S. Rubin, J. Sahel, C. I. Sánchez, D. Sanches Fernandes, M. Schmid, S. Schmitz-Valckenberg, A. Skelly, L. Stöhr, D. Taylor, J. Terheyden, A. Tufail, L. Vieweg, L. Wintergerst, C. Wojek, N. Zakaria, P. Zamiri |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 25% |
Belgium | 1 | 25% |
United Kingdom | 1 | 25% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 35 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 5 | 14% |
Student > Bachelor | 5 | 14% |
Researcher | 3 | 9% |
Student > Doctoral Student | 2 | 6% |
Lecturer | 1 | 3% |
Other | 2 | 6% |
Unknown | 17 | 49% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 31% |
Biochemistry, Genetics and Molecular Biology | 3 | 9% |
Nursing and Health Professions | 2 | 6% |
Computer Science | 1 | 3% |
Engineering | 1 | 3% |
Other | 0 | 0% |
Unknown | 17 | 49% |